Invesco NASDAQ Biotechnology ETF
IBBQ
14 hedge funds and large institutions have $7.3M invested in Invesco NASDAQ Biotechnology ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
1% more capital invested
Capital invested by funds: $7.23M → $7.3M (+$76.7K)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
16.11% less ownership
Funds ownership: 53.73% → 37.62% (-16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$270K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$233K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$38.2K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$18.4K |
| 5 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$879 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$317K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$37.5K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$12.5K |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$10.5K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$5.69K |
IBBQ Hedge Fund Activity: Q2 2023 in Review
14 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2023, worth a combined $7.3M — up 1.1% from $7.23M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IBBQ positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Partners Capital Investment Group, adding an estimated $270K. The largest seller was Citadel Advisors, exiting entirely with an estimated $317K sold.
- 14 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2023, up from 13 in Q1 2023.
- Funds reported $7.3M of Invesco NASDAQ Biotechnology ETF stock for Q2 2023, up 1.1% quarter-over-quarter.
- 2 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2023 and 1 closed out, a net change of +1 holder.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2023 was Partners Capital Investment Group, an estimated $270K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q2 2023 was Citadel Advisors, an estimated $317K sold.
Based on aggregated 13F filings for Q2 2023.